D K Edmonds

No ORCID on file · 10 papers in corpus · active 1989-1997

Study types

  • article 7
  • letter 2
  • rct 1

Condition tags

  • endometriosis 10
  • dysmenorrhea 1
  • dyspareunia 1
article 1997
Metabolism: clinical and experimental ·doi:10.1016/s0026-0495(97)90115-3
article 1996
British journal of obstetrics and gynaecology

Add-back hormone replacement therapy (HRT) can alleviate the undesirable hypo-oestrogenic effects of the gonadotrophin-releasing hormone (GnRH) agonists, including loss in bone mineral content. However, this approach presents a dilemma in p…

letter 1996
Thorax ·doi:10.1136/thx.51.10.1064
article 1995
Clinical endocrinology ·doi:10.1111/j.1365-2265.1995.tb02926.x

OBJECTIVE: GnRH analogues are being used increasingly for a number of oestrogen dependent conditions in women. The resultant profound hypo-oestrogenism is a disadvantage, however, but the preservation of pituitary sensitivity to negative fe…

rct 1995
Fertility and Sterility ·doi:10.1016/s0015-0282(16)57779-6

OBJECTIVE: To determine whether treatment of endometriosis with a GnRH analogue (GnRH-a; goserelin) combined with continuous estrogen and progestogen hormone replacement therapy (HRT) would prevent the hypoestrogenic effects, including loss…

article 1994
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1994.tb13681.x
article 1994
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a138788

The expression of receptors for the ovarian steroid hormones oestrogen and progesterone was studied immunohistochemically using monoclonal antibodies in samples of endometriosis and endometrium in 22 patients. In nine patients samples of en…

article 1991
Fertility and Sterility ·doi:10.1016/s0015-0282(16)54294-0
article 1990
Clinical endocrinology ·doi:10.1111/j.1365-2265.1990.tb03891.x

SUMMARY In an attempt to determine whether the suppression in oestradiol levels caused by danazol is due to an effect on the hypothalamic‐pituitary axis, we compared the endocrine effects of danazol with those of the LHRH (GnRH) agonist ana…

letter 1989
Lancet (London, England) ·doi:10.1016/s0140-6736(89)92659-7